DK3218351T3 - Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377 - Google Patents

Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377 Download PDF

Info

Publication number
DK3218351T3
DK3218351T3 DK15808087.9T DK15808087T DK3218351T3 DK 3218351 T3 DK3218351 T3 DK 3218351T3 DK 15808087 T DK15808087 T DK 15808087T DK 3218351 T3 DK3218351 T3 DK 3218351T3
Authority
DK
Denmark
Prior art keywords
ahu
insulating
procedure
manufacturing
applicable forms
Prior art date
Application number
DK15808087.9T
Other languages
English (en)
Inventor
Michal Voslar
Ales Halama
Pavel Zvatora
Ondrej Dammer
Jan Stach
Michal Zapadlo
Lukas Krejcik
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ2014-792A external-priority patent/CZ2014792A3/cs
Priority claimed from CZ2015-758A external-priority patent/CZ2015758A3/cs
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of DK3218351T3 publication Critical patent/DK3218351T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/06—Monoamines containing only n- or iso-propyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/07—Monoamines containing one, two or three alkyl groups, each having the same number of carbon atoms in excess of three
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK15808087.9T 2014-11-14 2015-11-11 Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377 DK3218351T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ2014-792A CZ2014792A3 (cs) 2014-11-14 2014-11-14 Způsob přípravy, izolace a čištění farmaceuticky využitelných forem AHU-377
CZ2015-758A CZ2015758A3 (cs) 2015-10-27 2015-10-27 Pevné formy vápenaté soli ethyl esteru (2R, 4S)-5-(bifenyl-4-yl)-4-[(3-karboxypropionyl)amino]-2-methylpentanové kyseliny, způsob jejich přípravy a použití
PCT/CZ2015/000136 WO2016074651A1 (en) 2014-11-14 2015-11-11 A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377

Publications (1)

Publication Number Publication Date
DK3218351T3 true DK3218351T3 (da) 2019-09-16

Family

ID=54848362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15808087.9T DK3218351T3 (da) 2014-11-14 2015-11-11 Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377

Country Status (8)

Country Link
EP (1) EP3218351B1 (da)
DK (1) DK3218351T3 (da)
ES (1) ES2745157T3 (da)
HU (1) HUE046278T2 (da)
LT (1) LT3218351T (da)
PL (1) PL3218351T3 (da)
PT (1) PT3218351T (da)
WO (1) WO2016074651A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3317248T (pt) 2015-07-02 2020-12-21 Novartis Ag Sais de cálcio de sacubitril
MX2018007129A (es) * 2015-12-11 2018-11-09 Zentiva Ks Formas solidas de ester etilico del acido (2r,4s)-5-(bifenil-4-il) -4-[(3-carboxipropionil)amino]-2-metil-pentanoico, sus sales y un metodo de preparacion.
EP3508479A4 (en) * 2016-09-02 2020-02-19 Noratech Pharmaceuticals, Inc. CRYSTALLINE FORMS OF VALSARTAN DISODIUM SALT
US10683260B2 (en) 2016-09-07 2020-06-16 Nanjing Noratech Pharmaceuticals Co., Ltd. Crystalline form of sacubitril sodium salt
CN106496055A (zh) * 2016-10-09 2017-03-15 杭州科巢生物科技有限公司 一种抗心衰新药的关键组分沙库比曲的新合成方法
EP3522886A4 (en) * 2016-10-10 2020-02-19 Laurus Labs Limited STABLE AMORPHE FORM OF THE SACUBITRIL VALSARTAN TRINATRIUM COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
WO2018078592A1 (en) 2016-10-28 2018-05-03 Biocon Limited Amorphous trisodium sacubitril valsartan and process for its preparation
CN107188817A (zh) * 2017-05-22 2017-09-22 杭州瑞法康科技有限公司 一种高纯度沙库比曲半钙盐一水合物的新晶型及其制备方法
CN107602410A (zh) * 2017-09-13 2018-01-19 浙江三门恒康制药有限公司 沙库比曲钠盐的晶型ii及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
DE60315795T2 (de) 2002-01-17 2008-06-05 Novartis Ag Pharmazeutische zusammensetzung enthaltend valsartan und nep-inhibitoren
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
EP1903027A1 (en) 2006-09-13 2008-03-26 Novartis AG Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
ES2602566T3 (es) 2007-01-12 2017-02-21 Novartis Ag Proceso para preparar ácido 5-bifenil-4-amino-2-metil pentanoico
AR070176A1 (es) 2008-01-17 2010-03-17 Novartis Ag Procesos de sintesis de inhibidores de nep, compuestos intermediarios y uso de los mismos en la sintesis
ES2550485T3 (es) 2010-01-22 2015-11-10 Novartis Ag Intermedios de inhibidores de la endopeptidasa neutra y método de preparación de los mismos
PT2609075E (pt) 2010-08-23 2016-06-03 Novartis Ag Processo para a preparação de intermediários para o fabrico de inibidores da nep
US9085529B2 (en) 2010-08-23 2015-07-21 Novartis Ag Process for the preparation of intermediates useful for the manufacture NEP inhibitors
AR092278A1 (es) 2012-08-31 2015-04-08 Novartis Ag Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
CN105168205A (zh) * 2015-08-18 2015-12-23 泰力特医药(湖北)有限公司 一种血管紧张素ii受体和脑啡肽酶受体双重抑制剂lcz696的制备方法

Also Published As

Publication number Publication date
PL3218351T3 (pl) 2019-12-31
WO2016074651A1 (en) 2016-05-19
HUE046278T2 (hu) 2020-02-28
EP3218351A1 (en) 2017-09-20
EP3218351B1 (en) 2019-06-19
LT3218351T (lt) 2019-09-25
ES2745157T3 (es) 2020-02-27
PT3218351T (pt) 2019-09-26

Similar Documents

Publication Publication Date Title
DK3134149T3 (da) Mikrokanyler og fremgangsmåder til fremstilling deraf
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3197356T3 (da) Fremgangsmåde til modusomkobling
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3171891T3 (da) Fremgangsmåde
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3230795T3 (da) Prægelak og fremgangsmåde til prægning
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3134084T3 (da) Fremgangsmåde til behandling af lungeadenokarcinom
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
HUE038343T2 (hu) Eljárás forrasztott kapcsolat kialakítására
DK3162258T3 (da) Kogekar og fremstillingsfremgangsmåde
DK3107949T3 (da) Sulfonerede copolyestere og fremgangsmåde til fremstilling
DK3259232T3 (da) Fremgangsmåde til aerogeler
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3023037T3 (da) Indretning og fremgangsmåde til frembringelse af mælkeskum
DK3314597T3 (da) Fjernstyring
DK3666258T3 (da) Fremgangsmåde til behandling af prader-willis syndrom
DK3113773T3 (da) Krystallinske former af grapiprant
IL254502A0 (en) Solid forms of menaquinols